Acrivon Therapeutics - דינמיקת הכנסות משנה לשנה ב-12 החודשים האחרונים ACRV

סמל מסחרי של Acrivon Therapeutics (ACRV)

The year-over-year percentage change in sales volume for LTM on the GURU.Markets base chart contains the value 0.00. Acrivon Therapeutics (ACRV) possesses significant market influence due to the inelastic demand for the APAM platform. An innovative approach to proteomic analysis enables therapy personalization. However, the narrow specialization of the pipeline creates substantial binary risks typical of early-stage biomedical development.

צמיחת מכירות משנה לשנה ב-12 החודשים האחרונים Acrivon Pharma (ACRV): לתקופה 11.02.2024 - 18.11.2026

פילוחי נתונים אנליטיים מרוכזים עבור Acrivon Pharma (ACRV)

- שווי מניות ותחזית קונצנזוס למחירים:
ניתוח כל מדדי החברה:Acrivon Pharma (ACRV)
מוצר סדרתי של Acrivon

For the biopharmaceutical sector of Acrivon Therapeutics (ACRV), this indicator serves as a filter for market noise. The annual sales growth rate (trailing 12 months) calculates the percentage change in revenue for the current year relative to the previous one. The price action on this chart separates random spikes from sustainable business scaling. For a company with the APPM IT platform, growth in this metric confirms the commercial efficiency of reducing R&D costs. A stable trend here signifies the fundamental viability of the biomarker selection model.